Jenna Beckham, MD, MSPH, FACOG, and Thomas Kimble, MD, comment on unmet needs and challenges faced by patients looking for contraception.
Experts discuss the trajectory of CMV awareness and vaccine development efforts.
Expanding peripartum prophylaxis could be more cost-effective, but would likely lead to significant over-treatment.
While physicians face many financial and legal risks, the elephant in the room is always your professional liability and the risk of a malpractice lawsuit. We start an in-depth look at the facts about these lawsuits including where they happen, who they happen to, and what they cost.
This diverse group of women came together to explore the challenges in treating mental illness in patients who identify as female.
Investing in customer experience strategies can improve customer satisfaction, raise employee retention and save companies money in the long term. Private practices that do not maintain digital prowess will have unhappy patients and unhappy employees.
Recommendations for maternity care professionals based on MiPATH.
Michael L. Krychman, MD, and Jack D. Sobel, MD, discuss the importance of awareness and education about RVVC, particularly given the impact of symptoms on patients’ psychosocial and sexual behavior.
Spot Her aims to educate people about the signs and risk factors of endometrial cancer, one of the most common yet under-recognized women’s cancers.
Effective treatment will depend on the diagnosis, but can range from simple to very complex.
Rachel Rubin, MD, an assistant clinical professor in urology at Georgetown University and a urologic surgeon, discusses how hypoactive sexual desire disorder in women was defined and treated historically.
This week the panel weighs in on treatments not specifically indicated for COVID-19 treatment, including metformin, and concerns around using medications in this way.
Kate White, MD, MPH, and Harold Bays, MD, discuss their hopes for the future of contraception options, affordability, and clinical trials evaluating their efficacy.
In the wake of the Supreme Court’s decision to overturn Roe v Wade, results of a recent study indicated that more than half of female patients treated with methotrexate, a commonly-prescribed drug used to manage rheumatic diseases, lived in states with abortion restrictions or bans.
Gynecologic providers should feel more comfortable proactively addressing the sexual well-being of their patients.
History, potential value, possible candidates, and limitations of PGT for in vitro fertilization.
These therapeutic medical devices can be used by patients to effectively treat pelvic pain and anxiety related to intercourse.
The cumulative probabilities of treatment initiation after meeting the criteria was not significantly different between the different racial groups and the incidence of major adverse liver outcomes was 0.1 per 100 person-years and did not differ by race.
Experts discuss the trajectory of CMV awareness and vaccine development efforts.
From the eradication of smallpox to the COVID-19 pandemic, vaccines have revolutionized health care, but rising vaccine hesitancy now threatens progress, especially among pregnant women.
Endometriosis experts describe their takeaway points messages on the management of endometriosis.
Teenaged girls at average risk don’t need Papanicolaou tests, but some special populations do.
How you can help patients during the current attack on their reproductive autonomy
A challenge in the prenatal management of FGR is differentiating the constitutionally small fetus with a normal neonatal outcome from one who is pathologically growth restricted and at risk for postnatal complications.
Results from one study found that many patients avoid going to the doctor because they feel uncomfortable seeking medical care or fear a serious illness. As providers, we need to recognize these issues and create a welcoming environment for all patients to ensure they don’t postpone care or avoid it entirely.
The following points summarize information from a Joint Statement of the Perinatal Quality Foundation, ACMG, ACOG, the Society for Maternal-Fetal Medicine (SMFM), and the National Society of Genetic Counselors on “points to consider” when performing expanded carrier screening in reproductive medicine.